• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于子宫内膜息肉的恶性肿瘤风险因素。

Malignancy risk factors based on endometrial polyp.

机构信息

Department of Obstetrics and Gynecology, Osmaniye State Hospital, Selimiye, Bölge Trafik Yanı, Musa Şahin Blv, 80000, Osmaniye, Merkez, Turkey.

Department of Gynecological Oncology, Nyala Sudan Turkish Training and Research Hospital, Nyala, South Darfur, Sudan.

出版信息

BMC Womens Health. 2024 Oct 21;24(1):567. doi: 10.1186/s12905-024-03406-3.

DOI:10.1186/s12905-024-03406-3
PMID:39434154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11492711/
Abstract

AIMS

This study aims to examine cases identified with endometrial polyp and carcinoma originating from polyps in patients presenting with gynaecological problems, and to highlight the significance of risk factors contributing to malignancy.

MATERIALS AND METHODS

The study comprised 203 patients who visited our clinic between January 2019 and 2024 with various gynaecological problems and were identified with endometrial polyps after a clinical, radiographic, and laboratory assessment. We retrospectively analysed data from 191 benign endometrial polyps and hyperplasia without atypia and 12 patients with endometrial polyps and underlying endometrial hyperplasia with atypia and/or endometrial carcinoma, diagnosed histopathologically after hysteroscopic resection, retrieved from our hospital's electronic archive system. Two hundred three participants were tested in the study, with 191 classifieds with benign tumours and 12 diagnosed with malignant tumours and atypical endometrial hyperplasia (premalignant). Cases were chosen according on consistent criteria for age, BMI, gravida, parity, abortion, educational level, smoking habits, operation history, and co-morbidities. After determining the sample size for the malignant group, patients from the control group were selected to be included in the study. Initially, patients with similar age and BMI distributions were included into the study. Next, the cases were analysed for similarities in gravida, parity, and abortion parameters, and those that matched were chosen. Following this step, the educational status was compared for resemblance, and examples with matching educational status were chosen. Consequently, the study covered a total of 34 patients, with 12 identified with malignant tumours and atypical endometrial hyperplasia (premalignant) and 22 with benign tumours. Two groups of cases were diagnosed with endometrial polyp, and risk factors that may cause the development of endometrial polyp and underlying carcinoma: age, gravida, parity, abortion, education level, smoking, previous operation history, comorbidity, gynaecological complaints, fasting blood sugar, CRP values, haemoglobin, and haematocrit were evaluated in terms of endometrial polyp sizes, endometrial thickness level, and endometrial polyp localization. By examining the pathological risk factors of these cases, particularly during the premenopausal period, the goal is to predict endometrial cancer, the most prevalent gynaecological cancer in women, along with its antecedents, and implement preventive measures proactively.

RESULTS

Age, BMI, gravida, parity, number of abortions, educational status, smoking status, operation history, co-morbidity, and complaint variables did not exhibit a statistically significant difference between the groups (p > 0.05). It was revealed that the FBG level, CRP level, Polyp length and Endometrial thickness level of the malignant group were statistically significantly higher than the benign group (p < 0.01) (p < 0.05). Upon analysing the FBG distribution among groups, it is noted that the ODDS ratio is 10.20 for FBG values of 122.5 and above (95% CI: 1.97 - 52.78). Upon analysing the CRP distribution by groups, it is noted that the ODDS ratio is 231 for CRP values of 9.7 and above (95% CI: 13.15 - 4058.67). Upon analysing the distribution of Polyp length based on groups, it was determined that the ODDS ratio is 13.5 for Polyp lengths of 2.25 and above (95% CI: 2.47 - 73.71). Upon analysing the distribution of EM thickness based on groups, it is shown that the ODDS ratio is 5.25 for EM thicknesses of 11 and above (95% CI: 1.09 - 25.21).

CONCLUSION

Endometrial polyps are common benign growths that are typically not seen as cancer precursors but may be linked to cancer in people with advanced age. It is vital to remember that in cases of endometrial polyps, variables such as increasing polyp length, endometrial thickness, fasting glucose level, and elevated CRP levels are significant risk factors for the development of cancer associated with polyps.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/629c/11492711/9c87e57f2770/12905_2024_3406_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/629c/11492711/9c87e57f2770/12905_2024_3406_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/629c/11492711/9c87e57f2770/12905_2024_3406_Fig1_HTML.jpg
摘要

目的

本研究旨在检查因妇科问题就诊并经临床、影像学和实验室评估后被诊断为子宫内膜息肉的患者中源自息肉的子宫内膜息肉和癌病例,并强调导致恶性肿瘤的风险因素的重要性。

材料和方法

本研究纳入了 203 名 2019 年 1 月至 2024 年期间因各种妇科问题就诊且经临床、影像学和实验室评估后被诊断为子宫内膜息肉的患者。我们回顾性分析了从我们医院电子档案系统中检索到的 191 例良性子宫内膜息肉和非典型增生无增生以及 12 例子宫内膜息肉和潜在子宫内膜增生伴不典型增生和/或子宫内膜癌的患者的数据,这些患者经宫腔镜切除术后组织病理学诊断。203 名参与者在研究中进行了测试,其中 191 例为良性肿瘤患者,12 例为恶性肿瘤和不典型子宫内膜增生(癌前病变)患者。根据年龄、BMI、孕次、产次、流产、教育水平、吸烟习惯、手术史和合并症等一致标准选择病例。确定恶性组的样本量后,从对照组中选择患者纳入研究。首先,将具有相似年龄和 BMI 分布的患者纳入研究。接下来,分析了孕次、产次和流产参数的相似性,并选择了匹配的病例。在这一步之后,比较了教育状况的相似性,并选择了具有匹配教育状况的例子。因此,该研究共包括 34 例患者,其中 12 例为恶性肿瘤和不典型子宫内膜增生(癌前病变)患者,22 例为良性肿瘤患者。两组患者均被诊断为子宫内膜息肉,并评估了可能导致子宫内膜息肉和潜在癌发展的风险因素:年龄、孕次、产次、流产、教育水平、吸烟、既往手术史、合并症、妇科主诉、空腹血糖、CRP 值、血红蛋白和血细胞比容与子宫内膜息肉大小、子宫内膜厚度水平和子宫内膜息肉定位有关。通过检查这些病例的病理危险因素,特别是在绝经前期间,旨在预测最常见的妇科癌症——子宫内膜癌及其前身,并主动采取预防措施。

结果

年龄、BMI、孕次、产次、流产次数、教育水平、吸烟状况、手术史、合并症和主诉变量在组间没有统计学差异(p>0.05)。结果表明,恶性组的 FBG 水平、CRP 水平、息肉长度和子宫内膜厚度水平均显著高于良性组(p<0.01)(p<0.05)。在分析组间 FBG 分布时,注意到 FBG 值为 122.5 及以上的 ODDS 比值为 10.20(95%CI:1.97-52.78)。在分析 CRP 分布时,注意到 CRP 值为 9.7 及以上的 ODDS 比值为 231(95%CI:13.15-4058.67)。在分析基于组的息肉长度分布时,确定息肉长度为 2.25 及以上的 ODDS 比值为 13.5(95%CI:2.47-73.71)。在分析基于组的 EM 厚度分布时,表明 EM 厚度为 11 及以上的 ODDS 比值为 5.25(95%CI:1.09-25.21)。

结论

子宫内膜息肉是常见的良性生长物,通常不被视为癌症前体,但在年龄较大的人群中可能与癌症有关。重要的是要记住,在子宫内膜息肉的情况下,息肉长度、子宫内膜厚度、空腹血糖水平和 CRP 水平升高等变量是与息肉相关癌症的重要危险因素。

相似文献

1
Malignancy risk factors based on endometrial polyp.基于子宫内膜息肉的恶性肿瘤风险因素。
BMC Womens Health. 2024 Oct 21;24(1):567. doi: 10.1186/s12905-024-03406-3.
2
Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies.子宫内膜息肉的癌前和恶性转化的机会和风险因素:管理策略。
J Minim Invasive Gynecol. 2010 Jan-Feb;17(1):53-8. doi: 10.1016/j.jmig.2009.10.012.
3
Nulliparity and postmenopausal status are independent factors of malignancy potential of endometrial intraepithelial neoplasia in polyps.多息肉中,原发性和绝经后状态是子宫内膜上皮内瘤变恶性潜能的独立因素。
Int J Gynaecol Obstet. 2021 Mar;152(3):433-438. doi: 10.1002/ijgo.13448. Epub 2020 Dec 15.
4
Clinical parameters linked with malignancy in endometrial polyps.与子宫内膜息肉恶性肿瘤相关的临床参数。
Climacteric. 2009 Oct;12(5):454-8. doi: 10.1080/13697130902912605.
5
Prediction of Premalignant and Malignant Endometrial Polyps by Clinical and Hysteroscopic Features.临床和宫腔镜特征预测癌前和恶性子宫内膜息肉。
J Minim Invasive Gynecol. 2019 Nov-Dec;26(7):1311-1315. doi: 10.1016/j.jmig.2018.12.018. Epub 2019 Jan 4.
6
Endometrial polyp size and polyp hyperplasia.子宫内膜息肉大小与息肉增生
Int J Gynaecol Obstet. 2013 Dec;123(3):236-9. doi: 10.1016/j.ijgo.2013.06.027. Epub 2013 Sep 3.
7
Atypical endometrial polyps and the incidence of endometrial cancer: a retrospective cohort study.非典型子宫内膜息肉与子宫内膜癌的发病风险:一项回顾性队列研究。
BJOG. 2020 Jul;127(8):994-999. doi: 10.1111/1471-0528.16194. Epub 2020 Apr 9.
8
Occurrence of malignancy in endometrial polyps during postmenopause.绝经后子宫内膜息肉恶变的发生情况。
Eur J Gynaecol Oncol. 2010;31(2):165-8.
9
Risk of malignancy on suspicion of polyps in menopausal women.绝经后女性息肉疑似恶变风险。
Eur J Obstet Gynecol Reprod Biol. 2017 Sep;216:138-142. doi: 10.1016/j.ejogrb.2017.07.013. Epub 2017 Jul 15.
10
Is the finding of endometrial hyperplasia or corporal polyp an mandatory indication for biopsy?子宫内膜增生或子宫体息肉的发现是活检的必要指征吗?
Ceska Gynekol. 2020 Winter;85(2):84-93.

本文引用的文献

1
Detection and Classification of Hysteroscopic Images Using Deep Learning.基于深度学习的宫腔镜图像检测与分类
Cancers (Basel). 2024 Mar 28;16(7):1315. doi: 10.3390/cancers16071315.
2
Removal of uterine polyps: clinical management and surgical approach.子宫息肉的去除:临床管理和手术方法。
Climacteric. 2020 Aug;23(4):388-396. doi: 10.1080/13697137.2020.1784870.
3
A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis.
高格拉斯哥预后评分(GPS)或改良的格拉斯哥预后评分(mGPS)可预测妇科恶性肿瘤的不良预后:系统评价和荟萃分析。
Arch Gynecol Obstet. 2020 Jun;301(6):1543-1551. doi: 10.1007/s00404-020-05581-8. Epub 2020 May 14.
4
Endometrial Polyp Size and the Risk of Malignancy in Asymptomatic Postmenopausal Women.无症状绝经后女性子宫内膜息肉大小与恶性风险
J Obstet Gynaecol Can. 2019 Jul;41(7):912-915. doi: 10.1016/j.jogc.2018.07.019. Epub 2018 Oct 27.
5
The risk of malignancy in uterine polyps: A systematic review and meta-analysis.子宫息肉恶性肿瘤风险:系统评价和荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2019 Jun;237:48-56. doi: 10.1016/j.ejogrb.2019.04.009. Epub 2019 Apr 15.
6
No. 249-Asymptomatic Endometrial Thickening.第249号——无症状子宫内膜增厚。
J Obstet Gynaecol Can. 2018 May;40(5):e367-e377. doi: 10.1016/j.jogc.2018.03.005.
7
ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding.美国妇产科医师学会委员会意见第 734 号:经阴道超声检查在评估绝经后出血女性子宫内膜中的作用。
Obstet Gynecol. 2018 May;131(5):e124-e129. doi: 10.1097/AOG.0000000000002631.
8
Risk of malignancy on suspicion of polyps in menopausal women.绝经后女性息肉疑似恶变风险。
Eur J Obstet Gynecol Reprod Biol. 2017 Sep;216:138-142. doi: 10.1016/j.ejogrb.2017.07.013. Epub 2017 Jul 15.
9
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.ESMO-ESGO-ESTRO 子宫内膜癌共识会议:诊断、治疗和随访。
Ann Oncol. 2016 Jan;27(1):16-41. doi: 10.1093/annonc/mdv484. Epub 2015 Dec 2.
10
Hyperglycemia as a risk factor for cancer progression.高血糖作为癌症进展的一个风险因素。
Diabetes Metab J. 2014 Oct;38(5):330-6. doi: 10.4093/dmj.2014.38.5.330.